Molecular and ctDNA Characterization of High-Risk Endometrial Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer — Stella

Home/Endometrial Carcinoma/

View on ClinicalTrials.gov

Recruiting

Back to Endometrial Carcinoma trials

Trial locations(1 site)

United States

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Sponsor

Mayo Clinic

Enrollment target

~100 participants

Started

October 2025

Primary completion

October 2028

Age range

18 Years and older

Sex

Female only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.